Latest News
Global investment manager Igneo Infrastructure Partners (Igneo), has reached an agreement to acquire a 100% interest in Elliott Green Power Australia (EGP) via its Australian renewables business, Atmos Renewables.
The EGP portfolio consists of the Childers, Susan River and Nevertire solar farms with a combined capacity of 302 MW, generating approximately 500GWh of energy annually and powering over 100,000 homes. Each solar farm includes well-advanced co-located battery developments totalling 125 MW / 250 MWhs. Construction of the battery projects is expected to commence in 2022.
The solar farms each have long term offtake agreements for energy and green certificates with
Moonhub has raised $2.6m in seed funding led by global proptech VC Pi Labs with participation from Ada Ventures, 1818 Venture Capital and numerous angel investor.
Founded in 2016, the London-based startup led by Dami Hastrup, Vinh Ly and Hannah Sutcliffe, has established itself as a leading force in the UK and is now set to expand its operations into the burgeoning global VR workplace training market, which consultancy PwC estimates will grow to $294 billion by 2030.
Moonhub’s employs patented VR technology to deliver a low risk, highly-immersive experience for learners and provides an analytical performance overview for
Epitopea, a transatlantic cancer immunotherapeutics company and global specialist in exploiting a new class of untapped tumour-specific antigens (TSAs), has secured a $13.6 million (£10.3 million) seed investment from a transatlantic syndicate of top-tier life sciences investors, including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital (CIC) and Fonds de solidarité FTQ.
The seed round was also supported by Novateur Ventures and the Harrington Discovery Institute/University Health Holdings.
The funding will leverage Epitopea’s Cryptigen approach to create transformational immunotherapies that target broad cancer patient populations in both solid and haematological cancers.
The seed round funding will be used to
Venture capital investment manager, Deepbridge Capital has deployed a record £31.5 million into early-stage technology and life sciences companies during the 2021/22 tax year, up from £29.4 million in 2020/21.
Providing private investors with access to portfolios of innovative and growth focused companies, Deepbridge manages the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS funds which offer private investors significant tax reliefs via the UK Government’s Enterprise Investment Scheme (EIS).
Some 52 companies received funding via Deepbridge in 2021/22, based across England, Scotland, Wales and Northern Ireland. Companies to receive funding included the likes of rocket propulsion pioneers
Fenergo, a provider of digital solutions for Know your Customer (KYC) and client lifecycle management (CLM), has acquired Sentinels, an anti-money laundering (AML) transaction monitoring new market entrant with artificial intelligence (AI) based technology.
The acquisition, for an undisclosed amount, strengthens Fenergo’s ability to deliver end-to-end Software as a Service (SaaS) based-CLM with smart transaction monitoring to financial institutions. The deal comes as the industry continues to be challenged by rising financial crime, evolving regulations, operational inefficiencies, and pressure to deliver a better customer experience.
Fenergo enables financial institutions to adhere to KYC and AML regulations while onboarding clients safely
British Patient Capital has invested £20 million in Cambridge Innovation Capital’s (CIC) second investment vehicle (CIC II). CIC was launched in 2013 and invests in deep-tech and life sciences businesses that have a connection with the Cambridge ecosystem.
The £20 million investment forms part of CIC II’s total fund size of £225 milion. The new fund will lead, or co-lead, investments in R&D intensive businesses across deep-tech and life sciences which have the potential to become global category leaders. They will predominantly be early-stage companies at their Series A round.
CIC II will invest in businesses with a link to
The Washington State Investment Board (WSIB) has made two new allocations totalling $370 million to two separate funds managed by TPG, according to a repot by AlternativesWatch.
The $155 billion investment has allocated $250 million to impact fund Rise Fund III, which will make growth equity, growth buyout and venture capital investments in growth‐stage businesses across multiple industry sectors.
In addition, the WSIB has made a sidecar allocation of up to $120 million in TPG Healthcare Partners II.
Albourne America recommended both funds with the investments extending WSIB’s private equity portfolio in-line with its existing 2022 PE annual investment plan.
Stonepeak, an alternative investment firm specialising in infrastructure and real assets, has appointed Daniel Wong as a senior managing director, head of Europe.
Based in the firm’s London office, Wong will oversee Stonepeak’s continued expansion into Europe and build on Stonepeak’s existing strengths in infrastructure, energy transition, and ESG. Daniel will also join the firm’s Executive Committee.
Wong joins Stonepeak following more than 22 years at Macquarie where most recently he served as Global Co-Head of Macquarie Capital, including as Global Head of Infrastructure & Energy, as well as a member of the Executive Committee of Macquarie Group.
CertiK, a global Web3 and blockchain security firm, has secured an additional $60 million investment from SoftBank Vision Fund 2 and Tiger Global.
This marks SoftBank’s first venture into the Web3 security space. CertiK’s $88 million series B3 round and $2 billion valuation were announced within the past month, led by Insight Partners. This additional funding brings the total amount invested in CertiK over the past nine months to $290 million USD.
CertiK’s mission is to secure the Web3 world through an end-to-end set of security services, providing clients with a one-stop-shop for all their security needs. Demand for industry-leading
Maven Capital Partners (Maven) has led a £1.5 million investment in Roman Ltd (“Roman”), a business that manufactures, sells and installs shower screens, trays, bathroom furniture and fixtures and fittings.
The transaction includes an £800,000 investment from the Finance Durham Fund (Finance Durham) established by Durham County Council and overseen by Business Durham, and a £700,000 investment from the North East Development Capital Fund (NEDCF), supported by the European Regional Development Fund.
The funding package will be used to support a significant increase in demand, invest in Roman’s 400,000 sq ft manufacturing plant in Newton Aycliffe to purchase new machinery
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
